News

The wait for UC Berkeley’s bold new home for research and innovation is nearly over.

If universities across the country want to equip their students with the skills to become innovative changemakers, translating knowledge and research from the classroom into practice must be a priority, said a panel of UC Berkeley leaders on Thursday.

But what is changemaking, and how is Berkeley incorporating that ethos into its curriculum?

Chancellor Carol Christ and Catherine Koshland, the interim executive vice chancellor and provost, sent the following message to the campus community on Thursday:

In just two weeks we will resume in-person instruction on a large scale for the first time since the pandemic began. This transition is being met with both excitement and trepidation. We know that this is a challenging time for some and want to take a moment to address some of the concerns we’re hearing and hopefully help put your mind at ease.

Marco Lobba was five years into his UC Berkeley chemistry Ph.D. program researching the revolutionary CRISPR-Cas9 protein when he found himself in an unfamiliar place: the front of a business school lecture hall.

It was January 2020 — a few months before the coronavirus pandemic began — and the second day of a Haas School of Business entrepreneurship course. Lobba had developed a new way of fusing proteins together that he thought could help treat autoimmune diseases like lupus, multiple sclerosis or Type 1 diabetes.

One year after admitting its most diverse freshmen class in 30 years, the University of California, Berkeley, has met or exceeded last year’s success in its admission of underrepresented minority students for fall 2021.

In a first, an NFT based on the digital data from a Nobel Prize-winning research created by the University of California, Berkeley alumni, was sold off at an auction for 22 ETH ($54,360), fetching the campus close to $50,000.

This first ever university-issued NFT, or non-fungible token, based on an invention was minted by UC Berkeley last month to honour the...

UC Berkeley will auction two nonfungible tokens, or NFTs, relating to Nobel Prize-winning inventions for the funding of future research and innovation.

The NFTs being sold include digital art pieces consisting of the original patent disclosure forms behind former campus professor James Allison’s cancer immunotherapy research, for which he shared the 2018 Nobel Prize in physiology or medicine, and CRISPR-Cas9 gene editing, for which campus biochemistry and molecular biology professor Jennifer Doudna shared the 2020 Nobel Prize in chemistry.

As an elementary student in East Palo Alto in the mid-2000s, Aurora Lopez was surrounded by Latinx students and families like her own. Although her neighborhood school lacked resources, she felt comfortable, at home with her peers and teachers.

Dr. Bryan Tegomoh wanted to help more patients. Tegomoh is a trained physician who grew up in Cameroon’s capital Yaounde. After spending two years in rural northwest Cameroon, he saw scores of some of the most vulnerable groups in the world falling sick with Hepatitis B, malaria and HIV-related infections. “My perspective began to change,” he shares.